UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

Toxicological impact of organic ultrafine particles (UFPs) in human bronchial epithelial BEAS-2B cells at air-liquid interface

Toxicology in vitro, 2022-02, Vol.78, p.105258-105258, Article 105258

2022

Volltextzugriff (PDF)

Subsarcolemmal and interfibrillar mitochondria display distinct superoxide production profiles

Free radical research, 2015-03, Vol.49 (3), p.331-337

2015

Volltextzugriff (PDF)

The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors

British journal of pharmacology, 2000-04, Vol.129 (7), p.1465-1473

2000

Volltextzugriff (PDF)

The interesting anti-H1 effects in maintenance insomnia: A reflection on the comparative advantages of doxylamine and doxepin

Encéphale, 2020-02, Vol.46 (1), p.80-82

2020

Volltextzugriff (PDF)

The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists

Psychopharmacology, 2000-02, Vol.148 (2), p.153-163

2000

Volltextzugriff (PDF)

Actions of adenosine at its receptors in the CNS: Insights from knockouts and drugs

Annual review of pharmacology and toxicology, 2005-01, Vol.45 (1), p.385-412

2005

Volltextzugriff (PDF)

Adenosine and Brain Function

International Review of Neurobiology, 2005, Vol.63, p.191-270

2005

Volltextzugriff (PDF)

Absence of the adenosine A2A receptor or its chronic blockade decrease ethanol withdrawal-induced seizures in mice

Neuropharmacology, 2001-03, Vol.40 (3), p.424-432

2001

Volltextzugriff (PDF)

Individual differences in response to imipramine in the mouse tail suspension test

Psychopharmacology, 1997-12, Vol.134 (4), p.387-391

1997

Volltextzugriff (PDF)

Adenosine A2A Receptor Gene Disruption Provokes Marked Changes in Melanocortin Content and Pro-Opiomelanocortin Gene Expression

Journal of neuroendocrinology, 2003-12, Vol.15 (12), p.1171-1177

2003

Volltextzugriff (PDF)

Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice

British journal of pharmacology, 2001-09, Vol.134 (1), p.68-77

2001

Volltextzugriff (PDF)

Behavioral, Neurochemical, and Electrophysiological Characterization of a Genetic Mouse Model of Depression

Proceedings of the National Academy of Sciences - PNAS, 2003-05, Vol.100 (10), p.6227-6232

2003

Volltextzugriff (PDF)

A genetic mouse model of helplessness sensitive to imipramine

European journal of pharmacology, 1996-12, Vol.316 (2), p.R1-R2

1996

Volltextzugriff (PDF)

Although Chemically Related to Amineptine, the Antidepressant Tianeptine Is Not a Dopamine Uptake Inhibitor

Pharmacology, biochemistry and behavior, 1999-06, Vol.63 (2), p.285-290

1999

Volltextzugriff (PDF)

Caffeine reduces hypnotic effects of alcohol through adenosine A 2A receptor blockade

Neuropharmacology, 2003, Vol.45 (7), p.977-985

2003

Volltextzugriff (PDF)

Indirect dopamine agonists effects on despair test: Dissociation from hyperactivity

Pharmacology, biochemistry and behavior, 1996-05, Vol.54 (1), p.235-239

1996

Volltextzugriff (PDF)

In vivo labelling of the adenosine A2A receptor in mouse brain using the selective antagonist [3H]SCH 58261

The European journal of neuroscience, 2001-11, Vol.14 (9), p.1567-1570

2001

Volltextzugriff (PDF)

Les effets anti-H1 intéressants dans les insomnies de maintien : réflexion sur les intérêts comparés de la doxylamine et de la doxépine

Encéphale, 2020-02, Vol.46 (1), p.80-82

2020

Volltextzugriff (PDF)

In vivo occupancy of the striatal dopamine uptake complex by various inhibitors does not predict their effects on locomotion

European journal of pharmacology, 1993-01, Vol.230 (2), p.195-201

1993

Volltextzugriff (PDF)

Pharmacological modifications of dopamine transmission do not influence the striatal in vivo binding of [ 3H]mazindol or [ 3H]cocaine in mice

Neuroscience letters, 1996-03, Vol.205 (3), p.145-148

1996

Volltextzugriff (PDF)

Adenosine A2A receptor knockout mice are partially protected against drug-induced catalepsy

Neuroreport, 2001-04, Vol.12 (5), p.983-986

2001

Volltextzugriff (PDF)

Behavioural and neurochemical evidence that the antimicrobial agent oxolinic acid is a dopamine uptake inhibitor

European neuropsychopharmacology, 1998-12, Vol.8 (4), p.255-259

1998

Volltextzugriff (PDF)

Ionic Requirements for the Specific Binding of [3H]GBR 12783 to a Site Associated with the Dopamine Uptake Carrier

Journal of neurochemistry, 1988-03, Vol.50 (3), p.759-765

1988

Volltextzugriff (PDF)

In vivo striatal binding of the D1 antagonist SCH 23390 is not modified by changes in dopaminergic transmission

Neuropharmacology, 1996-03, Vol.35 (3), p.267-272

1996

Volltextzugriff (PDF)

Two polygenic mouse models of major depressive disorders identify TMEM161B as a potential biomarker of disease in humans

Neuropsychopharmacology, 2024-06, Vol.49 (7), p.1129-1139

2024

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(73)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences
(35)
Human Health And Pathology
(32)
Animals
(31)
Mice
(30)
Male
(28)
Science & Technology
(26)
Life Sciences & Biomedicine
(23)
Biological And Medical Sciences
(22)
Medical Sciences
(15)
Neurosciences
(15)
Neurosciences & Neurology
(15)
Pharmacology & Pharmacy
(14)
Neuropharmacology
(13)
Pharmacology. Drug Treatments
(13)
Mice, Knockout
(12)
Disease Models, Animal
(10)
Female
(10)
Humans
(10)
Psychology. Psychoanalysis. Psychiatry
(10)
Fundamental And Applied Biological Sciences. Psychology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Toxicological impact of organic ultrafine particles (UFPs) in human bronchial epithelial BEAS-2B cells at air-liquid interface

Subsarcolemmal and interfibrillar mitochondria display distinct superoxide production profiles

The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors

The interesting anti-H1 effects in maintenance insomnia: A reflection on the comparative advantages of doxylamine and doxepin

The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists

Actions of adenosine at its receptors in the CNS: Insights from knockouts and drugs

Adenosine and Brain Function

Absence of the adenosine A2A receptor or its chronic blockade decrease ethanol withdrawal-induced seizures in mice

Individual differences in response to imipramine in the mouse tail suspension test

Adenosine A2A Receptor Gene Disruption Provokes Marked Changes in Melanocortin Content and Pro-Opiomelanocortin Gene Expression

Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice

Behavioral, Neurochemical, and Electrophysiological Characterization of a Genetic Mouse Model of Depression

A genetic mouse model of helplessness sensitive to imipramine

Although Chemically Related to Amineptine, the Antidepressant Tianeptine Is Not a Dopamine Uptake Inhibitor

Caffeine reduces hypnotic effects of alcohol through adenosine A 2A receptor blockade

Indirect dopamine agonists effects on despair test: Dissociation from hyperactivity

In vivo labelling of the adenosine A2A receptor in mouse brain using the selective antagonist [3H]SCH 58261

Les effets anti-H1 intéressants dans les insomnies de maintien : réflexion sur les intérêts comparés de la doxylamine et de la doxépine

In vivo occupancy of the striatal dopamine uptake complex by various inhibitors does not predict their effects on locomotion

Pharmacological modifications of dopamine transmission do not influence the striatal in vivo binding of [ 3H]mazindol or [ 3H]cocaine in mice

Adenosine A2A receptor knockout mice are partially protected against drug-induced catalepsy

Behavioural and neurochemical evidence that the antimicrobial agent oxolinic acid is a dopamine uptake inhibitor

Ionic Requirements for the Specific Binding of [3H]GBR 12783 to a Site Associated with the Dopamine Uptake Carrier

In vivo striatal binding of the D1 antagonist SCH 23390 is not modified by changes in dopaminergic transmission

Two polygenic mouse models of major depressive disorders identify TMEM161B as a potential biomarker of disease in humans

Suchergebnisse filtern